Skip to main content
Fig. 6 | Journal of Neuroinflammation

Fig. 6

From: MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin

Fig. 6

MOG-IgG titers and treatment status. While median MOG-IgG titers were lower during remission than during acute attacks in the treated subgroup (a), a similarly significant difference was also observed in the untreated subgroup (b). By contrast, no significant difference in median titers was observed between treated and untreated patients, neither during acute attacks nor during remission (not shown)

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094